AI in Genomics Market Report and Forecast 2025-2034
Description
The global AI in genomics market was valued at USD 664.12 Million in 2024, fueled by the rising emphasis on personalized medicine and advancements in AI-driven genomics solutions across the globe. The market is anticipated to grow at a CAGR of 32.40% during the forecast period of 2025-2034, with the values likely to reach USD 10993.26 Million by 2034.
AI in Genomics Market Overview
Artificial intelligence in genomics is transforming healthcare by analyzing large genomic datasets to expedite discoveries, lower expenses, and enhance precision medicine. Major factors involve AI's influence on the efficiency of drug discovery and improved clinical processes. Trends such as the integration of AI in genome sequencing and sophisticated diagnostics are increasing demand, setting the AI in genomics industry up for strong market expansion as worldwide dependence on AI-powered solutions escalates.
AI in Genomics Market Growth Drivers
Rising Applications in Drug Discovery and Development Drives Market Growth
AI is increasingly utilized in the drug discovery process because it can optimize research, lower development expenses, and decrease timelines. Through the analysis of genomic information, AI detects possible drug targets and streamlines the development process, greatly aiding the expansion of the AI in genomics market by improving efficiency and accelerating breakthroughs in personalized medicine.
AI in Genomics Market Trends
Several trends and developments are being observed in the market to enhance the current situation. The following are some of the noteworthy trends.
Rising Adoption of AI in Genome Sequencing
AI has witnessed significant adoption in genome sequencing, which enables better and sped-up data processing. This forms the basis for faster sequencing technologies, which allow the conducting of large-scale studies and breakthroughs in understanding genetic diseases, fuelling market growth for AI in genomics.
Growing Use of Machine Learning in Genomic Data Analysis
Machine learning algorithms are widely being applied to analyze complex genomic data and identify patterns to support research and clinical decoding. This trend favors the improved interpretation of data and hence drives the market demand for advanced AI solutions in genomics.
Expansion of AI-Based Diagnostics
AI in diagnostics is gaining importance, particularly due to its ability to detect genetic markers associated with several diseases. The expansion of AI-based diagnostics allows for earlier detection of disease and further enhances AI in the genomics market by catering to the demand for preventive and targeted care.
Advancements in Gene Editing with AI Assistance
AI is finding its application in various domains including gene editing. It may grant the researchers further aid in identifying target genes and acquiring predictions for achieved results. Hence, it adds to the precision of gene editing technologies like CRISPR. This aids the growth of the market mainly due to advancements in genomics applications of therapies.
AI in Genomics Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Component
Market Segmentation Based on End User Set to Witness Substantial Growth
Based on end users, the market is divided into pharmaceutical and biotech companies, healthcare providers, research and academic institutes, and others. Among these, the pharmaceutical and biotech companies are expected to dominate the market. The market share can be attributed to an increase in combining AI and machine learning for managing clinical data, predicting diseases, and identifying biomarkers, thereby improving the efficiency of drug development. These innovations facilitate easy, more affordable research, addressing the growing need for AI in genomics and fostering its overall growth.
AI in Genomics Market Analysis by Region
Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Among these, North America, with a strong healthcare system and leading healthcare companies, is projected to hold a substantial market share._x000D_
In the forecast period, the Asia Pacific region is expected to witness significant expansion. This can be attributed to heightened spending aimed at enhancing healthcare facilities and addressing varied patient needs. Due to the availability of skilled healthcare professionals, cost-effective treatments, and tailored care, nations such as India and South Korea are witnessing a rise in medical tourism.
Leading Players in the AI in Genomics Market
The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
IBM
Founded in 1911, it has its corporate headquarters in New York, USA. IBM is a multinational corporation in engineering technology and consulting. In the genomics sector, IBM Watson Health has collaborated with Illumina to impose standards and provide easier interpretation of genomic data.
Microsoft
Founded in 1975, it has its corporate headquarters in Redmond, Washington. Microsoft is a leader in software and cloud computing services worldwide. The company uses its Microsoft Genomics service, providing open-source and open-standard-based solutions on the Azure platform to allow genomic analysis and speed precision health initiatives.
Thermo Fisher Scientific Inc.
It was incorporated in 1956 with a corporate headquarters in Waltham, Massachusetts. The company supplies analytical instruments, laboratory equipment, and services to the genomics field, supporting research and clinical applications.
Illumina, Inc.
Founded in 1998 and headquartered in California, Illumina is a global leader in DNA sequencing and array-based technologies. The company is focused on innovation in genomics, serving customers within research, clinical, and applied markets.
Other companies include NVIDIA Corporation, DEEP GENOMICS, Data4Cure, Inc., Freenome Holdings, Inc., SOPHiA GENETICS, and BenevolentAI.
Key Questions Answered in the AI in Genomics Market
AI in Genomics Market Overview
Artificial intelligence in genomics is transforming healthcare by analyzing large genomic datasets to expedite discoveries, lower expenses, and enhance precision medicine. Major factors involve AI's influence on the efficiency of drug discovery and improved clinical processes. Trends such as the integration of AI in genome sequencing and sophisticated diagnostics are increasing demand, setting the AI in genomics industry up for strong market expansion as worldwide dependence on AI-powered solutions escalates.
AI in Genomics Market Growth Drivers
Rising Applications in Drug Discovery and Development Drives Market Growth
AI is increasingly utilized in the drug discovery process because it can optimize research, lower development expenses, and decrease timelines. Through the analysis of genomic information, AI detects possible drug targets and streamlines the development process, greatly aiding the expansion of the AI in genomics market by improving efficiency and accelerating breakthroughs in personalized medicine.
AI in Genomics Market Trends
Several trends and developments are being observed in the market to enhance the current situation. The following are some of the noteworthy trends.
Rising Adoption of AI in Genome Sequencing
AI has witnessed significant adoption in genome sequencing, which enables better and sped-up data processing. This forms the basis for faster sequencing technologies, which allow the conducting of large-scale studies and breakthroughs in understanding genetic diseases, fuelling market growth for AI in genomics.
Growing Use of Machine Learning in Genomic Data Analysis
Machine learning algorithms are widely being applied to analyze complex genomic data and identify patterns to support research and clinical decoding. This trend favors the improved interpretation of data and hence drives the market demand for advanced AI solutions in genomics.
Expansion of AI-Based Diagnostics
AI in diagnostics is gaining importance, particularly due to its ability to detect genetic markers associated with several diseases. The expansion of AI-based diagnostics allows for earlier detection of disease and further enhances AI in the genomics market by catering to the demand for preventive and targeted care.
Advancements in Gene Editing with AI Assistance
AI is finding its application in various domains including gene editing. It may grant the researchers further aid in identifying target genes and acquiring predictions for achieved results. Hence, it adds to the precision of gene editing technologies like CRISPR. This aids the growth of the market mainly due to advancements in genomics applications of therapies.
AI in Genomics Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Component
- Software
- Services
- Genome Sequencing
- Gene Editing
- Clinical Workflows
- Others
- Drug Discovery & Development
- Precision Medicine
- Diagnostics
- Other Applications
- Pharmaceutical and Biotech Companies
- Healthcare Providers
- Research and Academic Institutes
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Segmentation Based on End User Set to Witness Substantial Growth
Based on end users, the market is divided into pharmaceutical and biotech companies, healthcare providers, research and academic institutes, and others. Among these, the pharmaceutical and biotech companies are expected to dominate the market. The market share can be attributed to an increase in combining AI and machine learning for managing clinical data, predicting diseases, and identifying biomarkers, thereby improving the efficiency of drug development. These innovations facilitate easy, more affordable research, addressing the growing need for AI in genomics and fostering its overall growth.
AI in Genomics Market Analysis by Region
Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Among these, North America, with a strong healthcare system and leading healthcare companies, is projected to hold a substantial market share._x000D_
In the forecast period, the Asia Pacific region is expected to witness significant expansion. This can be attributed to heightened spending aimed at enhancing healthcare facilities and addressing varied patient needs. Due to the availability of skilled healthcare professionals, cost-effective treatments, and tailored care, nations such as India and South Korea are witnessing a rise in medical tourism.
Leading Players in the AI in Genomics Market
The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
IBM
Founded in 1911, it has its corporate headquarters in New York, USA. IBM is a multinational corporation in engineering technology and consulting. In the genomics sector, IBM Watson Health has collaborated with Illumina to impose standards and provide easier interpretation of genomic data.
Microsoft
Founded in 1975, it has its corporate headquarters in Redmond, Washington. Microsoft is a leader in software and cloud computing services worldwide. The company uses its Microsoft Genomics service, providing open-source and open-standard-based solutions on the Azure platform to allow genomic analysis and speed precision health initiatives.
Thermo Fisher Scientific Inc.
It was incorporated in 1956 with a corporate headquarters in Waltham, Massachusetts. The company supplies analytical instruments, laboratory equipment, and services to the genomics field, supporting research and clinical applications.
Illumina, Inc.
Founded in 1998 and headquartered in California, Illumina is a global leader in DNA sequencing and array-based technologies. The company is focused on innovation in genomics, serving customers within research, clinical, and applied markets.
Other companies include NVIDIA Corporation, DEEP GENOMICS, Data4Cure, Inc., Freenome Holdings, Inc., SOPHiA GENETICS, and BenevolentAI.
Key Questions Answered in the AI in Genomics Market
- What was the global AI in genomics market value in 2024?
- What is the global AI in genomics market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on the component?
- What is the market breakup based on the functionality?
- What is the market segmentation based on the application?
- What is the market breakup based on the end user?
- What are the major factors aiding the global AI in genomics market demand?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- What are the major global AI in genomics market trends?
- How does the rise in the geriatric population impact the market size?
- Who are the key players involved in the global AI in genomics market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
- What are the primary components of the AI in genomics market?
- What role does AI play in genome sequencing?
- How is AI applied in drug discovery and development?
- How do pharmaceutical and biotech companies utilize AI in genomics?
- What is the role of North America in AI-driven genomics?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global AI in Genomics Market Overview
- 3.1 Global AI in Genomics Market Historical Value (2018-2024)
- 3.2 Global AI in Genomics Market Forecast Value (2025-2034)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global AI in Genomics Market Landscape*
- 5.1 Global AI in Genomics Market: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global AI in Genomics Market: Product Landscape
- 5.2.1 Analysis by Component
- 5.2.2 Analysis by Application
- 6 Global AI in Genomics Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global AI in Genomics Market Segmentation (218-2034)
- 7.1 Global AI in Genomics Market (2018-2034) by Component
- 7.1.1 Market Overview
- 7.1.2 Software
- 7.1.3 Services
- 7.2 Global AI in Genomics Market (2018-2034) by Functionality
- 7.2.1 Market Overview
- 7.2.2 Genome Sequencing
- 7.2.3 Gene Editing
- 7.2.4 Clinical Workflows
- 7.2.5 Others
- 7.3 Global AI in Genomics Market (2018-2034) by Application
- 7.3.1 Market Overview
- 7.3.2 Drug Discovery & Development
- 7.3.3 Precision Medicine
- 7.3.4 Diagnostics
- 7.3.5 Other Applications
- 7.4 Global AI in Genomics Market (2018-2034) by End User
- 7.4.1 Market Overview
- 7.4.2 Pharmaceutical and Biotech Companies
- 7.4.3 Healthcare Providers
- 7.4.4 Research and Academic Institutes
- 7.4.5 Others
- 7.5 Global AI in Genomics Market (2018-2034) by Region
- 7.5.1 Market Overview
- 7.5.2 North America
- 7.5.3 Europe
- 7.5.4 Asia Pacific
- 7.5.5 Latin America
- 7.5.6 Middle East and Africa
- 8 North America AI in Genomics Market (218-2034)
- 8.1 North America AI in Genomics Market (2018-2034) by Component
- 8.1.1 Market Overview
- 8.1.2 Software
- 8.1.3 Services
- 8.2 North America AI in Genomics Market (2018-2034) by Functionality
- 8.2.1 Market Overview
- 8.2.2 Genome Sequencing
- 8.2.3 Gene Editing
- 8.2.4 Clinical Workflows
- 8.2.5 Others
- 8.3 North America AI in Genomics Market (2018-2034) by Application
- 8.3.1 Market Overview
- 8.3.2 Drug Discovery & Development
- 8.3.3 Precision Medicine
- 8.3.4 Diagnostics
- 8.3.5 Other Applications
- 8.4 North America AI in Genomics Market (2018-2034) by End User
- 8.4.1 Market Overview
- 8.4.2 Pharmaceutical and Biotech Companies
- 8.4.3 Healthcare Providers
- 8.4.4 Research and Academic Institutes
- 8.4.5 Others
- 8.5 North America AI in Genomics Market (2018-2034) by Country
- 8.5.1 United States of America
- 8.5.2 Canada
- 9 Europe AI in Genomics Market (218-2034)
- 9.1 Europe AI in Genomics Market (2018-2034) by Component
- 9.1.1 Market Overview
- 9.1.2 Software
- 9.1.3 Services
- 9.2 Europe AI in Genomics Market (2018-2034) by Functionality
- 9.2.1 Market Overview
- 9.2.2 Genome Sequencing
- 9.2.3 Gene Editing
- 9.2.4 Clinical Workflows
- 9.2.5 Others
- 9.3 Europe AI in Genomics Market (2018-2034) by Application
- 9.3.1 Market Overview
- 9.3.2 Drug Discovery & Development
- 9.3.3 Precision Medicine
- 9.3.4 Diagnostics
- 9.3.5 Other Applications
- 9.4 Europe AI in Genomics Market (2018-2034) by End User
- 9.4.1 Market Overview
- 9.4.2 Pharmaceutical and Biotech Companies
- 9.4.3 Healthcare Providers
- 9.4.4 Research and Academic Institutes
- 9.4.5 Others
- 9.5 Europe AI in Genomics Market (2018-2034) by Country
- 9.5.1 United Kingdom
- 9.5.2 Germany
- 9.5.3 France
- 9.5.4 Italy
- 9.5.5 Others
- 10 Asia Pacific AI in Genomics Market (218-2034)
- 10.1 Asia Pacific AI in Genomics Market (2018-2034) by Component
- 10.1.1 Market Overview
- 10.1.2 Software
- 10.1.3 Services
- 10.2 Asia Pacific AI in Genomics Market (2018-2034) by Functionality
- 10.2.1 Market Overview
- 10.2.2 Genome Sequencing
- 10.2.3 Gene Editing
- 10.2.4 Clinical Workflows
- 10.2.5 Others
- 10.3 Asia Pacific AI in Genomics Market (2018-2034) by Application
- 10.3.1 Market Overview
- 10.3.2 Drug Discovery & Development
- 10.3.3 Precision Medicine
- 10.3.4 Diagnostics
- 10.3.5 Other Applications
- 10.4 Asia Pacific AI in Genomics Market (2018-2034) by End User
- 10.4.1 Market Overview
- 10.4.2 Pharmaceutical and Biotech Companies
- 10.4.3 Healthcare Providers
- 10.4.4 Research and Academic Institutes
- 10.4.5 Others
- 10.5 Asia Pacific AI in Genomics Market (2018-2034) by Country
- 10.5.1 China
- 10.5.2 Japan
- 10.5.3 India
- 10.5.4 ASEAN
- 10.5.5 Australia
- 10.5.6 Others
- 11 Latin America AI in Genomics Market (218-2034)
- 11.1 Latin America AI in Genomics Market (2018-2034) by Component
- 11.1.1 Market Overview
- 11.1.2 Software
- 11.1.3 Services
- 11.2 Latin America AI in Genomics Market (2018-2034) by Functionality
- 11.2.1 Market Overview
- 11.2.2 Genome Sequencing
- 11.2.3 Gene Editing
- 11.2.4 Clinical Workflows
- 11.2.5 Others
- 11.3 Latin America AI in Genomics Market (2018-2034) by Application
- 11.3.1 Market Overview
- 11.3.2 Drug Discovery & Development
- 11.3.3 Precision Medicine
- 11.3.4 Diagnostics
- 11.3.5 Other Applications
- 11.4 Latin America AI in Genomics Market (2018-2034) by End User
- 11.4.1 Market Overview
- 11.4.2 Pharmaceutical and Biotech Companies
- 11.4.3 Healthcare Providers
- 11.4.4 Research and Academic Institutes
- 11.4.5 Others
- 11.5 Latin America AI in Genomics Market (2018-2034) by Country
- 11.5.1 Brazil
- 11.5.2 Argentina
- 11.5.3 Mexico
- 11.5.4 Others
- 12 Middle East and Africa AI in Genomics Market (218-2034)
- 12.1 Middle East and Africa AI in Genomics Market (2018-2034) by Component
- 12.1.1 Market Overview
- 12.1.2 Software
- 12.1.3 Services
- 12.2 Middle East and Africa AI in Genomics Market (2018-2034) by Functionality
- 12.2.1 Market Overview
- 12.2.2 Genome Sequencing
- 12.2.3 Gene Editing
- 12.2.4 Clinical Workflows
- 12.2.5 Others
- 12.3 Middle East and Africa AI in Genomics Market (2018-2034) by Application
- 12.3.1 Market Overview
- 12.3.2 Drug Discovery & Development
- 12.3.3 Precision Medicine
- 12.3.4 Diagnostics
- 12.3.5 Other Applications
- 12.4 Middle East and Africa AI in Genomics Market (2018-2034) by End User
- 12.4.1 Market Overview
- 12.4.2 Pharmaceutical and Biotech Companies
- 12.4.3 Healthcare Providers
- 12.4.4 Research and Academic Institutes
- 12.4.5 Others
- 12.5 Middle East and Africa AI in Genomics Market (2018-2034) by Country
- 12.5.1 Saudi Arabia
- 12.5.2 United Arab Emirates
- 12.5.3 Nigeria
- 12.5.4 South Africa
- 12.5.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication Year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 14 Clinical Trials Analysis
- 14.1 Analysis by Trial Registration Year
- 14.2 Analysis by Trial Status
- 14.3 Analysis by Trial Phase
- 14.4 Analysis by Therapeutic Area
- 14.5 Analysis by Geography
- 15 Grants Analysis
- 15.1 Analysis by Year
- 15.2 Analysis by Amount Awarded
- 15.3 Analysis by Issuing Authority
- 15.4 Analysis by Grant Application
- 15.5 Analysis by Funding Institute
- 15.6 Analysis by NIH Departments
- 15.7 Analysis by Recipient Organization
- 16 Funding and Investment Analysis
- 16.1 Analysis by Funding Instances
- 16.2 Analysis by Drug Class of Funding
- 16.3 Analysis by Funding Amount
- 16.4 Analysis by Leading Players
- 16.5 Analysis by Leading Investors
- 16.6 Analysis by Geography
- 17 Strategic Initiatives
- 17.1 Analysis by Partnership Instances
- 17.2 Analysis by Drug Class of Partnership
- 17.3 Analysis by Leading Players
- 17.4 Analysis by Geography
- 18 Supplier Landscape
- 18.1 Market Share Analysis, By Region (Top 5 Companies)
- 18.1.1 Market Share Analysis: Global
- 18.1.2 Market Share Analysis: North America
- 18.1.3 Market Share Analysis: Europe
- 18.1.4 Market Share Analysis: Asia Pacific
- 18.1.5 Market Share Analysis: Others
- 18.2 IBM
- 18.2.1 Financial Analysis
- 18.2.2 Product Portfolio
- 18.2.3 Demographic Reach and Achievements
- 18.2.4 Company News and Development
- 18.2.5 Certifications
- 18.3 Microsoft
- 18.3.1 Financial Analysis
- 18.3.2 Product Portfolio
- 18.3.3 Demographic Reach and Achievements
- 18.3.4 Company News and Development
- 18.3.5 Certifications
- 18.4 NVIDIA Corporation
- 18.4.1 Financial Analysis
- 18.4.2 Product Portfolio
- 18.4.3 Demographic Reach and Achievements
- 18.4.4 Company News and Development
- 18.4.5 Certifications
- 18.5 DEEP GENOMICS
- 18.5.1 Financial Analysis
- 18.5.2 Product Portfolio
- 18.5.3 Demographic Reach and Achievements
- 18.5.4 Company News and Development
- 18.5.5 Certifications
- 18.6 Data4Cure, Inc.
- 18.6.1 Financial Analysis
- 18.6.2 Product Portfolio
- 18.6.3 Demographic Reach and Achievements
- 18.6.4 Company News and Development
- 18.6.5 Certifications
- 18.7 Freenome Holdings, Inc.
- 18.7.1 Financial Analysis
- 18.7.2 Product Portfolio
- 18.7.3 Demographic Reach and Achievements
- 18.7.4 Company News and Development
- 18.7.5 Certifications
- 18.8 Thermo Fisher Scientific Inc.
- 18.8.1 Financial Analysis
- 18.8.2 Product Portfolio
- 18.8.3 Demographic Reach and Achievements
- 18.8.4 Company News and Development
- 18.8.5 Certifications
- 18.9 Illumina, Inc.
- 18.9.1 Financial Analysis
- 18.9.2 Product Portfolio
- 18.9.3 Demographic Reach and Achievements
- 18.9.4 Company News and Development
- 18.9.5 Certifications
- 18.10 SOPHiA GENETICS
- 18.10.1 Financial Analysis
- 18.10.2 Product Portfolio
- 18.10.3 Demographic Reach and Achievements
- 18.10.4 Company News and Development
- 18.10.5 Certifications
- 18.11 BenevolentAI
- 18.11.1 Financial Analysis
- 18.11.2 Product Portfolio
- 18.11.3 Demographic Reach and Achievements
- 18.11.4 Company News and Development
- 18.11.5 Certifications
- 19 Global AI in Genomics Market – Distribution Model (Additional Insight)
- 19.1 Overview
- 19.2 Potential Distributors
- 19.3 Key Parameters for Distribution Partner Assessment
- 20 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
